Newswise — A vaccine that could offer protection against COVID-19 and the flu has received positive results during trials.According to the drug maker, Moderna the shot called mRNA-1083 showed encouraging results among older adults.
The trial for the dual-purpose vaccine involved more than four thousand adults ages 65 or older. The vaccine triggered immune responses to three flu variants and SARS-CoV-2 virus which causes COVID.
George Washington University has experts available who can offer insight and analysis. If you would like to schedule an interview, please contact Katelyn Deckelbaum, [email protected].
Amanda Castel, is a professor of epidemiology at the GW Milken Institute School of Public Health and an expert in infectious diseases. She has served as an Epidemic Intelligence Service officer for the U.S. Centers for Disease Control and Prevention, spent over a decade working with local and state health departments and is board certified in pediatrics and preventive medicine and public health.
Michael Knight, is an assistant professor of medicine at GW School of Medicine and Health Sciences. He can discuss COVID-19 and the flu and what we know about the Moderna trial.
Maria Elena Ruiz is an associate professor of medicine and an infectious disease expert at the GW School of Medicine and Health Sciences. She can discuss COVID-19 and flu transmission and protection.
Emily R. Smith, is an assistant professor of global health at the GW Milken Institute School of Public Health. She is an epidemiologist who can discuss COVID-19, the flu and the dual purpose vaccine.
Adriana Glenn is an assistant professor in the GW School of Nursing. She can discuss COVID-19, the flu, its symptoms and analysis of the vaccine in trial.
RSS